Investing Profile

Jack Kenney(3)

VCInvestor

Associate at SV Health Investors

svhealthinvestors.comBoston, Massachusetts
Photo of Jack Kenney, Associate at SV Health Investors

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Notre Dame Network
16 CONNECTIONS
cb
$30K - $3.0M
$1.5M
5
£200M
CompanyStageDateRound SizeTotal Raised
Xilio Therapeutics
Series BMar 2020$100M
$330M
Co-investors: Mike Ross (SV Health Investors), Jayson Punwani (Abingworth), Peter Dudek (MRL Ventures Fund), Nancy Hong (RiverVest), Andrew Hack (Bain Capital Life Sciences)
Cellinta
SeedFeb 2020$5M
$5M
Catamaran Bio
SeedJan 2020$4.5M
$47M
Co-investors: Houman Ashrafian (SV Health Investors), Maina Bhaman (Soffinova Partners), Caroline Gaynor (Lightstone Ventures)
Caraway Therapeutics
Series ANov 2018$23M
$46M
Co-investors: John Gustofson (AbbVie Ventures)
Pionyr Immunotherapeutics
Series AJan 2017$8.5M
$71M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Arjun Goyal (Vida Ventures), Leon Chen (The Column Group)
Companies developing medicines to treat, modify, or cure severe diseases, including cancer, neurodegeneration, genetic disease, infection, and other medical needs. We seek companies positioned to outperform due to world-class management, innovative science, and competitive differentiation.
Associate SV Health Investors2019 - Present
Senior Analyst ClearView Healthcare Partners2017 - 2019
College of the Holy Cross A.B. Chemistry, Economics
University of Notre Dame M.S. Engineering, Science & Technology Entrepreneurship